Verona pharma announces november 2020 virtual investor conference participation

London and raleigh, n.c., nov. 09, 2020 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that david zaccardelli, chief executive officer and president, will present a company overview at the following virtual investor conferences in november 2020:
VRNA Ratings Summary
VRNA Quant Ranking